GENova, a company in the biotechnology field that concentrates on life threatening diseases, has hired Aaron Whiteman as CEO. With Whiteman in charge, GENova hopes to advance towards a goal of offering personalized cancer treatment strategies that will be safer to the human body.
Whiteman has an impressive resume that should serve him well in his new role. He graduated from Oxford University and has worked with a number of the top companies in the industry including Biogen Idec, Medarex, Myriad Genetics, Amgen and Pfizer.
“I am excited to provide the executive leadership to take GENova to its next stage of growth,” …read more

“Once regarded as irrelevant to economic activity, environmental problems are drastically rewriting the rules for business, investors, and consumers, affecting over $100 billion in annual capital flows,” say Worldwatch Institute project co-directors Gary Gardner and Thomas Prugh.
The world’s first global, sustainable market is becoming a reality according to a new report from the Worldwatch Institute. Environmental initiatives, revolutionary industrial production methods and a surge in environmentally focused investment groups are all highlighted among the increasingly important role that environmental issues play in the new world economy.
Another sign of dramatic change is the 575 environmental and energy hedge funds now in …read more